Mesoblast (MESO) Cash from Operations (2016 - 2023)

Mesoblast (MESO) posted quarterly Cash from Operations of 16278000.0 for Q2 2023, down 17.16% year-on-year from 19649568.38 in Q2 2022, and little changed on a QoQ basis from 16250000.0 in Q1 2023.

Mesoblast (MESO) Cash from Operations (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has reported Cash from Operations for 8 consecutive years, with 16278000.0 the latest figure, recorded in Q2 2023.

  • Quarterly Cash from Operations fell 17.16% year-over-year to 16278000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 63269000.0 (up 3.82% YoY) and the FY2025 annual result came in at 50000000.0, down 3.18% from the prior year.
  • Cash from Operations steadied at 16278000.0 in Q2 2023 per MESO's latest filing, from 16250000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for MESO reached as high as 1330000.0 in Q4 2019 and fell as low as 30580000.0 in Q4 2020.
  • A 5-year average of 17882333.33 and a median of 17326500.0 in 2021 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2020 — Cash from Operations plunged 2199.25% — and 2021, when it jumped 40.42%.
  • Year by year, Cash from Operations stood at 1330000.0 in 2019, then tumbled by 2199.25% to 30580000.0 in 2020, then surged by 40.42% to 18219000.0 in 2021, then rose by 9.69% to 16454000.0 in 2022, then advanced by 1.07% to 16278000.0 in 2023.
  • According to Business Quant data, Cash from Operations over the past three periods registered 16278000.0, 16250000.0, and 16454000.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -16.28 Mn
Jun 30, 2023 -16.28 Mn
Mar 31, 2023 -16.25 Mn
Mar 31, 2023 -16.25 Mn
Dec 31, 2022 -16.45 Mn
Dec 31, 2022 -16.45 Mn
Sep 30, 2022 -14.29 Mn
Sep 30, 2022 -14.29 Mn
Jun 30, 2022 -13.89 Mn
Jun 30, 2022 -13.89 Mn
Mar 31, 2022 -15.47 Mn
Mar 31, 2022 -15.47 Mn
Dec 31, 2021 -18.22 Mn
Dec 31, 2021 -18.22 Mn
Sep 30, 2021 -18.20 Mn
Sep 30, 2021 -18.20 Mn
Jun 30, 2021 -18.92 Mn
Jun 30, 2021 -18.92 Mn
Mar 31, 2021 -24.47 Mn
Mar 31, 2021 -24.47 Mn